Back to Search
CHARLES CASAT, M.D.
M.D.
Psychiatry Physician
NPI: 1497788673Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry Physician
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
9401147(NC)
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
9401147(NC)
Research & Publications (16)
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
PMID 18281409·Am J Psychiatry·2008
4-observational
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
PMID 17979588·J Child Adolesc Psychopharmacol·2007
8-other
Treatment for Adolescents with Depression Study (TADS): safety results.
PMID 17135989·J Am Acad Child Adolesc Psychiatry·2006
2-rct
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
PMID 16389216·Arch Pediatr Adolesc Med·2006
4-observational
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
PMID 17135987·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
PMID 17135986·J Am Acad Child Adolesc Psychiatry·2006
2-rct
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
PMID 15231966·Pediatrics·2004
3-trial
Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
PMID 15167084·J Am Acad Child Adolesc Psychiatry·2004
3-trial
Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
PMID 15167085·J Am Acad Child Adolesc Psychiatry·2004
3-trial
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
PMID 15502600·J Am Acad Child Adolesc Psychiatry·2004
3-trial
Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
PMID 15801334·J Atten Disord·2004
3-trial
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
PMID 12547477·Biol Psychiatry·2003
3-trial
Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.
PMID 12544181·J Am Acad Child Adolesc Psychiatry·2003
3-trial
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
PMID 12108801·J Am Acad Child Adolesc Psychiatry·2002
3-trial
Efficacy of olanzapine in social anxiety disorder: a pilot study.
PMID 12503837·J Psychopharmacol·2002
3-trial
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
PMID 12411225·Am J Psychiatry·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- BEHAVIORAL HEALTH CENTER CMC RANDOLPH, 501 BILLINGSLEY ROAD
CHARLOTTE, NC 28211 - Phone
- (704) 358-2700
Quick Facts
- NPI
- 1497788673
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile